Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04778397
Title Study to Evaluate the Safety and Efficacy of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Previously Untreated Adults With TP53 Mutant Acute Myeloid Leukemia (ENHANCE-2)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Gilead Sciences

acute myeloid leukemia


Cytarabine + Idarubicin

Azacitidine + Venetoclax

Azacitidine + Hu5F9-G4

Cytarabine + Daunorubicin

Age Groups: adult | senior
Covered Countries USA | FRA

Additional content available in CKB BOOST